Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

MRD Testing in Multiple Myeloma: Modeling the Potential Clinical and Economic Outcomes Based on the Master Trial

David Elsea, Josh J Carlson, Benjamin Eckert, Anthony Hewitt, Luciano J. Costa

Blood (2024) 144 (Supplement 1): 5028.

https://doi.org/10.1182/blood-2024-198502

Published: 2024

Journal Articles

Cost-Effectiveness of Implementing Clonoseq NGS-MRD Testing Using the Emory MRD Decision Protocol in Multiple Myeloma

Josh J Carlson, MPH, PhD, Marita Zimmermann, MPH, PhD, Audrey Demaree, PharmD, Tony Hewitt, Benjamin Eckert, Ajay Nooka, MDMPH

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-143234

Published: 2020

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

Cost-Effectiveness Assessment of Brentuximab Vedotin to Prevent Progression Following Autologous Stem Cell Transplant in Hodgkin Lymphoma in the United States

Joshua A Roth, PhD MHA, Josh J Carlson, MPH, PhD, Scott D Ramsey, MD PhD

Blood (2014) 124 (21): 2657.

https://doi.org/10.1182/blood.V124.21.2657.2657

Published: 2014

Journal Articles

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

LeShara M Fulton, BA, Michael J Carlson, PhD, James Coghill, MD, Michelle L. West, BS, Angela Panoskaltisis-Mortari, PhD, Bruce R. Blazar, MD, Dan Littman, PhD, Jonathan Serody, MD

Blood (2010) 116 (21): 3742.

https://doi.org/10.1182/blood.V116.21.3742.3742

Published: 2010

Journal Articles

Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells

James M. Coghill, Michael J. Carlson, Angela Panoskaltsis-Mortari, Michelle L. West, Joseph E. Burgents, Bruce R. Blazar, Jonathan S. Serody

Blood (2010) 115 (23): 4914–4922.

https://doi.org/10.1182/blood-2009-08-239848

Published: 2010

Includes: Supplemental data

Journal Articles

CCR1 Is Required for Treg-Mediated Protection From Lethal Acute Graft-Versus-Host Disease.

Michael J Carlson, PhD, James M. Coghill, MD, Michelle L. West, B.S., Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Jonathan S Serody, MD

Blood (2009) 114 (22): 1337.

https://doi.org/10.1182/blood.V114.22.1337.1337

Published: 2009

Journal Articles

In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

Michael J. Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis-Mortari, Bruce R. Blazar, Jonathan S. Serody

Blood (2009) 113 (6): 1365–1374.

https://doi.org/10.1182/blood-2008-06-162420

Published: 2009

Includes: Supplemental data

Journal Articles

TH17 Cells Mediate Extensive Skin Pathology in Acute GVHD.

Michael J. Carlson, PhD, Jonathan S. Serody, MD

Blood (2007) 110 (11): 2166.

https://doi.org/10.1182/blood.V110.11.2166.2166

Published: 2007

Journal Articles

CD62L Is Not Critical for T Regulatory Cell-Mediated Protection from Lethal Acute GVHD.

Michael J. Carlson, PhD, Hans E. Siedel, BS, Jonathan S. Serody, MD

Blood (2007) 110 (11): 2178.

https://doi.org/10.1182/blood.V110.11.2178.2178

Published: 2007

Journal Articles

Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation

J Carlson, GB Nash, V Gabutti, F al-Yaman, M Wahlgren

Blood (1994) 84 (11): 3909–3914.

https://doi.org/10.1182/blood.V84.11.3909.bloodjournal84113909

Published: 1994

Journal Articles

Physical Properties of Red Cells as Related to Effects in Vivo. III. Effect of Thermal Treatment on Survival of Red Cells in the Dog. Role of the Spleen

DENNIS J. CARLSON, M.D., THOMAS HALE HAM, M.D.

Blood (1968) 32 (6): 872–883.

https://doi.org/10.1182/blood.V32.6.872.872

Published: 1968

NARROW

MRD Testing in Multiple Myeloma: Modeling the Potential Clinical and Economic Outcomes Based on the Master Trial

Cost-Effectiveness of Implementing Clonoseq NGS-MRD Testing Using the Emory MRD Decision Protocol in Multiple Myeloma

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Cost-Effectiveness Assessment of Brentuximab Vedotin to Prevent Progression Following Autologous Stem Cell Transplant in Hodgkin Lymphoma in the United States

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells

CCR1 Is Required for Treg-Mediated Protection From Lethal Acute Graft-Versus-Host Disease.

In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

TH17 Cells Mediate Extensive Skin Pathology in Acute GVHD.

CD62L Is Not Critical for T Regulatory Cell-Mediated Protection from Lethal Acute GVHD.

Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation

Physical Properties of Red Cells as Related to Effects in Vivo. III. Effect of Thermal Treatment on Survival of Red Cells in the Dog. Role of the Spleen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only